https://novapharmanews.com/apac/news/tga-digital-mental-health-tools-consultation-update 2026-07-22T16:01:11.878Z NovaPharmaNews en 2026-07-22T02:22:26.701Z TGA Digital Mental Health Tools Consultation Update Psychiatry https://novapharmanews.com/apac/news/telix-q2-revenue-us247m-pipeline-progress 2026-07-22T16:01:09.765Z NovaPharmaNews en 2026-07-22T02:22:26.701Z Telix Q2 Revenue Hits US$247M; Pipeline Advances Illuccix, Gozellix, Pixclara, Oncology https://novapharmanews.com/apac/news/chinese-drugmakers-struggle-recruit-apac-expansion 2026-07-22T08:39:28.905Z NovaPharmaNews en 2026-07-22T02:22:26.701Z Chinese drugmakers struggle to recruit in APAC Oncology https://novapharmanews.com/apac/news/tga-spevigo-spesolimab-gpp-adolescents-australia 2026-07-22T16:01:22.049Z NovaPharmaNews en 2026-07-22T02:22:26.701Z TGA expands SPEVIGO for adolescent GPP care spesolimab, SPEVIGO, Dermatology https://novapharmanews.com/apac/news/china-clinical-trial-advantage-oncology-go-east 2026-07-22T08:40:43.386Z NovaPharmaNews en 2026-07-22T02:22:26.701Z China trial speed draws oncology go-East plans ADRX-0405, Ori-C101, Oncology https://novapharmanews.com/apac/news/global-clinical-trials-market-176b-apac-ai-dct 2026-07-22T08:39:44.334Z NovaPharmaNews en 2026-07-22T02:22:26.701Z Clinical trials market to $176B; APAC DCT rise Clinical Research https://novapharmanews.com/apac/news/hansoh-hs-10541-nmpa-clinical-trial-approval-kras-g12c 2026-07-22T16:01:22.263Z NovaPharmaNews en 2026-07-22T02:22:26.701Z Hansoh HS-10541 NMPA trial nod for KRAS G12C HS-10541, Oncology https://novapharmanews.com/apac/news/cup-comp-blood-based-molecular-profiling-cancer-unknown-primary 2026-07-22T08:20:49.567Z NovaPharmaNews en 2026-07-22T02:22:26.701Z CUP-COMP: blood profiling beats tissue in CUP Oncology https://novapharmanews.com/apac/news/tga-radiopharmaceutical-regulation-tc99m-supply-apac 2026-07-22T16:01:13.953Z NovaPharmaNews en 2026-07-22T02:22:26.701Z Asia-Pacific medical radioisotopes supply TGA technetium-99m, lutetium-177, Radiopharmaceuticals https://novapharmanews.com/eu/news/eu-uk-regulator-roundup-20-july-2026 2026-07-22T16:03:14.623Z NovaPharmaNews en 2026-07-22T02:15:40.668Z EU/UK Regulator Round-up: 20 July 2026 https://novapharmanews.com/uploads/articles/eu-uk-regulator-roundup-20-july-2026.webp EU/UK Regulator Round-up: 20 July 2026 https://novapharmanews.com/eu/news/chinese-drugmakers-struggle-recruit-eu-expansion 2026-07-22T06:56:57.810Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Chinese drugmakers struggle to recruit for EU rezvilutamide, Oncology https://novapharmanews.com/eu/news/lilly-ataibeckley-2-8b-deal-eu-uk-psychedelic-regulation 2026-07-22T14:26:50.297Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Eli Lilly to Acquire AtaiBeckley for $2.8B Psychiatry https://novapharmanews.com/uploads/articles/lilly-ataibeckley-2-8b-deal-eu-uk-psychedelic-regulation.webp Eli Lilly to Acquire AtaiBeckley for $2.8B https://novapharmanews.com/eu/news/zentalis-esmo-2026-azenosertib-denali-os-aspenova 2026-07-22T06:56:57.716Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Zentalis Pharmaceuticals to Present at ESMO Oncology https://novapharmanews.com/eu/news/ema-emer-cooke-speech-european-parliament-sant-committee-2026 2026-07-22T16:03:16.585Z NovaPharmaNews en 2026-07-22T02:15:40.668Z EMA Emer Cooke speech at EP SANT panel https://novapharmanews.com/uploads/articles/ema-emer-cooke-speech-european-parliament-sant-committee-2026.webp EMA Emer Cooke speech at EP SANT panel https://novapharmanews.com/eu/news/ema-chmp-etcamah-camizestrant-esr1-breast-cancer 2026-07-22T16:03:23.861Z NovaPharmaNews en 2026-07-22T02:15:40.668Z EMA Backs Etcamah for ESR1+ Breast Cancer Etcamah, camizestrant, Oncology https://novapharmanews.com/eu/news/incyte-esmo-2026-rapid-oral-presentations-madrid 2026-07-22T15:34:58.893Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Incyte Data to Be Highlighted in ESMO 2026 Madrid Oncology https://novapharmanews.com/eu/news/ema-apitegromab-sma-review-delay-manufacturing-inspection 2026-07-22T16:03:08.302Z NovaPharmaNews en 2026-07-22T02:15:40.668Z EMA Review of Apitegromab in Spinal SMA Delayed apitegromab, Neurology https://novapharmanews.com/eu/news/regulating-ai-in-drug-discovery-ema-fda-ich-eu-sponsors 2026-07-22T08:40:22.879Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Regulating AI in drug discovery: EMA FDA ICH Regulatory Science https://novapharmanews.com/eu/news/acadia-daybu-chmp-positive-opinion-rett-syndrome 2026-07-22T16:03:23.636Z NovaPharmaNews en 2026-07-22T02:15:40.668Z Acadia Daybu CHMP OK for Rett syndrome DAYBU, trofinetide, Rare Diseases https://novapharmanews.com/us/news/commissioner-s-national-priority-voucher-cnpv-pilot-program 2026-07-22T15:58:06.934Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Commissioner National Priority Voucher CNPV Pilot Regulatory Policy https://novapharmanews.com/uploads/articles/commissioner-s-national-priority-voucher-cnpv-pilot-program.webp Commissioner National Priority Voucher CNPV Pilot https://novapharmanews.com/us/news/compounded-glp-1s-why-doctors-worry-and-the-fda-is-cracking-down 2026-07-22T15:58:08.615Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Compounded GLP-1s Why doctors worry and FDA acts semaglutide, tirzepatide, Metabolic Disorders https://novapharmanews.com/uploads/articles/compounded-glp-1s-why-doctors-worry-and-the-fda-is-cracking-down.webp Compounded GLP-1s Why doctors worry and FDA acts https://novapharmanews.com/us/news/fda-finalizes-guidance-on-clinical-trial-design-for-psychedelic-drug-development 2026-07-22T15:58:46.649Z NovaPharmaNews en 2026-07-22T02:01:43.261Z FDA Finalizes Guidance on Clinical Trial Design Psychiatry https://novapharmanews.com/uploads/articles/fda-finalizes-guidance-on-clinical-trial-design-for-psychedelic-drug-development.webp FDA Finalizes Guidance on Clinical Trial Design https://novapharmanews.com/us/news/summit-therapeutics-refocuses-on-oncology-drug-after-antibiotic-sale 2026-07-22T16:14:40.275Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Summit Therapeutics Refocuses on Oncology Drug ridinilazole, ivonescimab, Oncology https://novapharmanews.com/uploads/articles/summit-therapeutics-refocuses-on-oncology-drug-after-antibiotic-sale.webp Summit Therapeutics Refocuses on Oncology Drug https://novapharmanews.com/us/news/study-china-outpaces-the-us-in-cancer-approvals-lags-behind-on-first-approvals 2026-07-22T15:58:37.512Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Study China outpaces the US in cancer approvals Oncology https://novapharmanews.com/uploads/articles/study-china-outpaces-the-us-in-cancer-approvals-lags-behind-on-first-approvals.webp Study China outpaces the US in cancer approvals https://novapharmanews.com/us/news/drug-repurposing-stakeholders-say-fda-should-act-within-its-authority-avoid-disi 2026-07-22T15:58:13.648Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Drug Repurposing Stakeholders Say FDA Should Act https://novapharmanews.com/uploads/articles/drug-repurposing-stakeholders-say-fda-should-act-within-its-authority-avoid-disi.webp Drug Repurposing Stakeholders Say FDA Should Act https://novapharmanews.com/us/news/fda-approves-merck-s-oral-pcsk9-drug-a-first 2026-07-22T15:58:04.502Z NovaPharmaNews en 2026-07-22T02:01:43.261Z FDA approves Merck oral PCSK9 drug enlicitide, LIPFENDRA, Cardiology https://novapharmanews.com/uploads/articles/fda-approves-merck-s-oral-pcsk9-drug-a-first.webp FDA approves Merck oral PCSK9 drug https://novapharmanews.com/us/news/lexitas-ocusun-dose-first-patient-in-pilot-study-for-age-related-cataract-eye-dr 2026-07-22T15:58:06.116Z NovaPharmaNews en 2026-07-22T02:01:43.261Z Lexitas Ocusun dose first patient in cataract pilot Ophthalmology https://novapharmanews.com/uploads/articles/lexitas-ocusun-dose-first-patient-in-pilot-study-for-age-related-cataract-eye-dr.webp Lexitas Ocusun dose first patient in cataract pilot https://novapharmanews.com/us/news/fda-approves-new-breast-cancer-drug-based-on-viktoria-1-study-results 2026-07-22T15:58:11.151Z NovaPharmaNews en 2026-07-22T02:01:43.261Z FDA Approves New Breast Cancer Drug Revtorpyk Revtorpyk, Oncology https://novapharmanews.com/uploads/articles/fda-approves-new-breast-cancer-drug-based-on-viktoria-1-study-results.webp FDA Approves New Breast Cancer Drug Revtorpyk https://novapharmanews.com/us/news/fda-activity-round-up-july-2026 2026-07-22T15:58:07.795Z NovaPharmaNews en 2026-07-22T02:01:43.261Z FDA Activity Round Up July 2026 https://novapharmanews.com/uploads/articles/fda-activity-round-up-july-2026.webp FDA Activity Round Up July 2026